Clinical Trial Update: Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of combining trifluridine/tipiracil with fufuquitinib as third-line therapy for metastatic colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fufuquitinib (Fufuquitinib)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Metastatic Colorectal Cancer, Drug Therapy | Phase 2 | Status: RECRUITING